Clinical Autonomic Research

, Volume 28, Issue 1, pp 131–132 | Cite as

Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome?

Letter to the Editor

Notes

Compliance with ethical standards

Conflict of interest

There are no conflicts of interest to disclose.

Funding

No funding has been received for this work.

References

  1. 1.
    Y-Hassan S, Tornvall P (2017) Epidemiology, pathogenesis, and management of takotsubo syndrome. Clin Auton Res.  https://doi.org/10.1007/s10286-017-0465-z
  2. 2.
    Y-Hassan S, Henareh L (2015) Plasma catecholamine levels in patients with takotsubo syndrome: implications for the pathogenesis of the disease. Int J Cardiol 181:35–38CrossRefPubMedGoogle Scholar
  3. 3.
    Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G et al (2005) Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352:539–548CrossRefPubMedGoogle Scholar
  4. 4.
    Christensen TE, Bang LE, Holmvang L, Skovgaard DC, Oturai DB, Søholm H et al (2016) (123)I-MIBG scintigraphy in the subacute state of Takotsubo cardiomyopathy. JACC Cardiovasc Imaging 9:982–990CrossRefPubMedGoogle Scholar
  5. 5.
    Madias JE A proposal for a noninvasive monitoring of sympathetic nerve activity in patients with takotsubo syndrome Med Hypotheses (in press) Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Icahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Division of CardiologyElmhurst Hospital CenterElmhurstUSA

Personalised recommendations